This piece is part of a package on the future of quantum computing. Read about the quest to develop these machines here and their most promising applications here. Around the world researchers are ...

Utilities are confronting a convergence of challenges, including aging infrastructure, rising energy demand and the accelerating shift to renewable energy sources. The electric grid, much of which is ...

Utility technology company Itron, Inc. has disclosed that an unauthorized third party accessed some of its internal systems during a cyberattack. The company states that it activated its cybersecurity ...

MIKE and Earl Sweatshirt resent the weight of expectation. After each of their prior records, fans were quick to project their own assumptions onto the pair, but both rappers have been equally fast to ...

I wore the world's first HDR10 smart glasses TCL's new E Ink tablet beats the Remarkable and Kindle Anker's new charger is one of the most unique I've ever seen Best laptop cooling pads Best flip ...

In an appearance at BlackRock’s U.S. Infrastructure Summit on Wednesday, OpenAI CEO Sam Altman offered a surprisingly clear articulation of how he imagines the future of artificial intelligence—it’s ...

For utilities today, implementing technology for vegetation management is a bit like the adage about “building the plane while it’s flying.” Manual and paper processes persist, and where technology ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. New data has revealed which states have to pay the most, and least, for ...

Step-by-step assembly of a custom DIY gaming PC, showcasing essential components and process for building a personalized, high-performance computer from scratch. Pixabay, Lixxe Building a computer ...

Losing important computer data can be a nightmare. Whether due to hardware failure, accidental deletion, software corruption, or theft, data loss can disrupt your work and personal life. Regularly ...

Atezolizumab With Bevacizumab and Nonplatinum Chemotherapy for Recurrent Ovarian Cancer: Final Results From the Placebo-Controlled AGO-OVAR 2.29/ENGOT-ov34 Phase III Trial For the model, we used ...